TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 21261705

Group type: EXPERIMENTAL
Intervention: Music exposure (Music for Dreaming, Sound Impressions, Pty. Ltd.) at 50‐55 decibel A
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (no music exposure)
Number of subjects: 20
Study: 18292426

Group type: EXPERIMENTAL
Intervention: 70% xenon
Number of subjects: 75

Group type: COMPARATOR
Intervention: 70% nitrous oxide
Number of subjects: 75
Study: 16551778

Group type: EXPERIMENTAL
Intervention: Computed Tomographic Angiography (CTA)
Number of subjects: 116
Study: 12666865

Group type: EXPERIMENTAL
Intervention: Surgical tube drain before primary closure
Number of subjects: 13

Group type: COMPARATOR
Intervention: Primary closure alone (no drain)
Number of subjects: 13
Study: 10881243

Group type: EXPERIMENTAL
Intervention: Testosterone supplementation (KS+T)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: No testosterone supplementation (KS-T)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Normal control subjects
Number of subjects: 20
Study: 9547134

Group type: EXPERIMENTAL
Intervention: Sertraline (50-150 mg/day)
Number of subjects: 400

Group type: COMPARATOR
Intervention: Citalopram (20-60 mg/day)
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 400
Study: 8507759

Group type: EXPERIMENTAL
Intervention: Rifampicin and doxycycline for 4 weeks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Trimethoprim-sulfamethoxazole for 6 months
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Doxycycline for 6 weeks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Streptomycin for 2 or 3 weeks with doxycycline for 6 weeks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Rifampicin with doxycycline for 6 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Monotherapy (single-agent therapy)
Number of subjects: 0
Study: 3324441

Group type: EXPERIMENTAL
Intervention: SolcoUrovac
Number of subjects: 400

Group type: COMPARATOR
Intervention: Nitrofurantoin or another appropriate antibiotic
Number of subjects: 400
Study: 29913392

Group type: EXPERIMENTAL
Intervention: Erector Spinae Plane Block (ESPB)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Standard multimodal analgesia
Number of subjects: 30
Study: 27764102

Group type: EXPERIMENTAL
Intervention: Seasonal Malaria Chemoprevention (SMC) with sulfadoxine-pyrimethamine plus amodiaquine (SPAQ) administered once per month from September to November.
Number of subjects: 780000
Study: 24951234

Group type: EXPERIMENTAL
Intervention: Treadmill workstation
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Elliptical trainer workstation
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Bicycle ergometer workstation
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Standing workstation
Number of subjects: 15

Group type: COMPARATOR
Intervention: Sitting workstation
Number of subjects: 15
Study: 22956016

Group type: EXPERIMENTAL
Intervention: Bilateral superficial cervical plexus block (BSCPB) with 20 mL of 0.525% ropivacaine
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Local wound infiltration (LWI) with 20 mL of 0.525% ropivacaine
Number of subjects: 97

Group type: COMPARATOR
Intervention: Isotonic sodium chloride solution (Control group)
Number of subjects: 97
Study: 20816190

Group type: EXPERIMENTAL
Intervention: Exposure to community violence (ECV)
Number of subjects: 397
Study: 18484388

Group type: EXPERIMENTAL
Intervention: Instructor-led programme
Number of subjects: 0

Group type: COMPARATOR
Intervention: Self-directed learning module
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 3.5-day workshops
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Internet-based teaching modules
Number of subjects: 0
Study: 15728422

Group type: EXPERIMENTAL
Intervention: Moderately intensive pool exercise therapy (twice a week for 12 weeks)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Control group (continued previous activities)
Number of subjects: 46
Study: 11322867

Group type: EXPERIMENTAL
Intervention: Nesiritide (0.2 microgram/kg bolus followed by 0.01 microgram/kg/min continuous infusion)
Number of subjects: 0

Group type: COMPARATOR
Intervention: iv. nitroglycerine
Number of subjects: 0
Study: 9675835

Group type: EXPERIMENTAL
Intervention: Disposable gastroscope (G-F100)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Standard gastroscope (GIF-Q 30)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Both gastroscopes
Number of subjects: 40
Study: 8002639

Group type: EXPERIMENTAL
Intervention: KW-2307 at 15 mg/m2
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: KW-2307 at 20 mg/m2
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: KW-2307 at 20 mg/m2 or higher doses
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: KW-2307 at 25 mg/m2
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: KW-2307 combined with cisplatin (CDDP) at 80 mg/m2
Number of subjects: 25
Study: 2510523

Group type: EXPERIMENTAL
Intervention: Gatekeeper plan
Number of subjects: 0

Group type: COMPARATOR
Intervention: Plan without a gatekeeper
Number of subjects: 0
Study: 818046

Group type: EXPERIMENTAL
Intervention: Intravenous Ara A
Number of subjects: 0

Group type: COMPARATOR
Intervention: Topical antiviral agents (IDU)
Number of subjects: 0
Study: 6903906

Group type: EXPERIMENTAL
Intervention: Structured, informative in-home teaching concerning infant behavior
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (no structured teaching)
Number of subjects: 30
Study: 30712743

Group type: EXPERIMENTAL
Intervention: Pilates exercises performed three times a week for 12 weeks
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 50
Study: 28222801

Group type: EXPERIMENTAL
Intervention: Injection of 6 × 10^6 hADSCs per 3 ml suspended in phosphate buffer saline
Number of subjects: 18

Group type: COMPARATOR
Intervention: Injection of 3 ml phosphate buffer saline (placebo)
Number of subjects: 18
Study: 24771618

Group type: EXPERIMENTAL
Intervention: Intensive lifestyle intervention (ILI)
Number of subjects: 2327
Study: 22884184

Group type: EXPERIMENTAL
Intervention: Dynamic splint (during the day) + routine care (exercises and advice for 8 weeks)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Routine care (exercises and advice for 8 weeks)
Number of subjects: 40
Study: 20000291

Group type: EXPERIMENTAL
Intervention: PRK
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Thin-flap LASIK
Number of subjects: 25

Group type: COMPARATOR
Intervention: Comparison between PRK and Thin-flap LASIK
Number of subjects: 25
Study: 17314444

Group type: EXPERIMENTAL
Intervention: Topical garlic gel with betamethasone cream 0.1%
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo with betamethasone cream 0.1%
Number of subjects: 40
Study: 15153582

Group type: EXPERIMENTAL
Intervention: Randomized controlled trials in podiatric medicine
Number of subjects: 0
Study: 11161545

Group type: EXPERIMENTAL
Intervention: GH treatment (12 U/dose) for 5 h
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: GH treatment (12 U/dose) for 5 days
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 30
Study: 9806287

Group type: EXPERIMENTAL
Intervention: SMART1 (protein-free medium)
Number of subjects: 93

Group type: COMPARATOR
Intervention: FertiCult (HSA containing medium)
Number of subjects: 93
Study: 7983614

Group type: EXPERIMENTAL
Intervention: High level of extrinsic need for job security (nSec)
Number of subjects: 383

Group type: COMPARATOR
Intervention: Absence of extrinsic need for job security (nSec)
Number of subjects: 383

Group type: EXPERIMENTAL
Intervention: High level of extrinsic need for job security (nSec) in subjects over 50 years old
Number of subjects: 383

Group type: EXPERIMENTAL
Intervention: Correlational association between nAch and LOC
Number of subjects: 383
Study: 3056498

Group type: EXPERIMENTAL
Intervention: Norethisterone acetate 1 mg (group A)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Norethisterone acetate 0.5 mg (group B)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Megestrol acetate 5 mg (group C)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Megestrol acetate 2.5 mg (group D)
Number of subjects: 60
Study: 31226957

Group type: EXPERIMENTAL
Intervention: Andilaye intervention
Number of subjects: 50

Group type: COMPARATOR
Intervention: Standard of care sanitation and hygiene programming (CLTSH)
Number of subjects: 50
Study: 28668855

Group type: EXPERIMENTAL
Intervention: Acetium® lozenge (slow-release L-Cysteine)
Number of subjects: 1998

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1998
Study: 26964163

Group type: EXPERIMENTAL
Intervention: Hooking therapy followed by safflower injection, once every 6 to 7 days, under local anesthesia. If efficacy was not satisfactory, a second treatment was given.
Number of subjects: 60

Group type: COMPARATOR
Intervention: Safflower injection applied to three points of lumbar region, once a day for 2 sessions (7 treatments per session).
Number of subjects: 60
Study: 24136585

Group type: EXPERIMENTAL
Intervention: Clopidogrel 75 mg/day
Number of subjects: 271
Study: 21259343

Group type: EXPERIMENTAL
Intervention: BoNT‐A (250 U Dysport)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: BoNT‐B (2500 U Neurobloc)
Number of subjects: 27
Study: 19404150

Group type: EXPERIMENTAL
Intervention: Intraoperative normothermia (36 degrees C‐37 degrees C)
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Intraoperative hypothermia (32.5 degrees C‐33.5 degrees C)
Number of subjects: 1000
Study: 16381068

Group type: EXPERIMENTAL
Intervention: Diazepam (0.19 mg/kg oral)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 15259328

Group type: EXPERIMENTAL
Intervention: Visuo-verbal test
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Verbal test
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 50
Study: 11479462

Group type: EXPERIMENTAL
Intervention: Reduced-dose recombinant tPA (8 mg bolus followed by 42 mg infusion)
Number of subjects: 400

Group type: COMPARATOR
Intervention: Urokinase (1.5 million units as a 30-minute infusion)
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Reduced-dose recombinant tPA
Number of subjects: 400

Group type: COMPARATOR
Intervention: Urokinase
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 400
Study: 9725479

Group type: EXPERIMENTAL
Intervention: Codeine phosphate (25 mg)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Ibuprofen (200 mg)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Codeine phosphate (25 mg) and Ibuprofen (200 mg) in association
Number of subjects: 24
Study: 8306744

Group type: EXPERIMENTAL
Intervention: Nasal intermittent positive pressure ventilation (NIPPV)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Conservative treatment (Control)
Number of subjects: 10
Study: 2686494

Group type: EXPERIMENTAL
Intervention: labetalol, 2 mg/min to a maximum of 300 mg
Number of subjects: 91

Group type: COMPARATOR
Intervention: sodium nitroprusside in 0.5 micrograms.kg‐1.min‐1 increments
Number of subjects: 91
Study: 31795966

Group type: EXPERIMENTAL
Intervention: Individualised breast cancer risk information (breast cancer prevention programme)
Number of subjects: 2094

Group type: COMPARATOR
Intervention: Individualised breast cancer, cardiovascular disease and type 2 diabetes information (multiple disease prevention programme)
Number of subjects: 2094
Study: 28159420

Group type: EXPERIMENTAL
Intervention: Postdischarge mechanical compression device (MCD) therapy
Number of subjects: 100

Group type: COMPARATOR
Intervention: Inpatient mechanical compression device (MCD) therapy
Number of subjects: 100
Study: 26159065

Group type: EXPERIMENTAL
Intervention: Gefitinib 250 mg once daily plus cisplatin 75 mg/m2 and pemetrexed 500 mg/m2 chemotherapy
Number of subjects: 265

Group type: COMPARATOR
Intervention: Placebo once daily plus cisplatin 75 mg/m2 and pemetrexed 500 mg/m2 chemotherapy
Number of subjects: 265

Group type: EXPERIMENTAL
Intervention: Gefitinib
Number of subjects: 265

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 265
Study: 23732584

Group type: EXPERIMENTAL
Intervention: Sildenafil
Number of subjects: 180

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 180
Study: 21195076

Group type: EXPERIMENTAL
Intervention: Modified Behavioural Pain Scale (MBPS)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Neonatal Infant Pain Scale (NIPS)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Face Legs Activity Cry Consolability Scale (FLACC)
Number of subjects: 120

Group type: COMPARATOR
Intervention: PCV vaccine
Number of subjects: 120

Group type: COMPARATOR
Intervention: DPTaP-Hib vaccine
Number of subjects: 120
Study: 19943711

Group type: COMPARATOR
Intervention: Topical diclofenac solution (40 drops four times daily)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Topical diclofenac solution (50 drops three times daily)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Topical diclofenac solution
Number of subjects: 0
Study: 17847938

Group type: EXPERIMENTAL
Intervention: PUVA therapy
Number of subjects: 60

Group type: COMPARATOR
Intervention: Local corticosteroid therapy
Number of subjects: 60
Study: 15166685

Group type: EXPERIMENTAL
Intervention: Lorazepam, 0.5-1.0 mg orally at bedtime for 7 days
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Zopiclone, 3.75-7.5 mg orally at bedtime for 7 days
Number of subjects: 18

Group type: COMPARATOR
Intervention: Zopiclone
Number of subjects: 18

Group type: COMPARATOR
Intervention: Lorazepam
Number of subjects: 18
Study: 11248744

Group type: EXPERIMENTAL
Intervention: 5 microg/kg per day rhGH administered subcutaneously at 2200 h for four days
Number of subjects: 19
Study: 9303394

Group type: EXPERIMENTAL
Intervention: Foscarnet cream
Number of subjects: 302

Group type: COMPARATOR
Intervention: Vehicle control
Number of subjects: 302
Study: 8322650

Group type: EXPERIMENTAL
Intervention: 3-minute infusion of adenosine (140 micrograms/kg/min)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: 6-minute infusion of adenosine (140 micrograms/kg/min)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Both 3-minute and 6-minute infusions of adenosine
Number of subjects: 11
Study: 3505706

Group type: EXPERIMENTAL
Intervention: Behaviorally oriented group therapy (4 months)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Waiting-list control
Number of subjects: 17
Study: 30173337

Group type: EXPERIMENTAL
Intervention: Therapeutic contact lenses (TCL)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Tight bandage patching
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 60
Study: 27053155

Group type: EXPERIMENTAL
Intervention: One Stretch exercise intervention with a 30-minute seminar and exercise manual
Number of subjects: 167

Group type: EXPERIMENTAL
Intervention: One Stretch exercise intervention
Number of subjects: 167

Group type: COMPARATOR
Intervention: Control group received only the manual
Number of subjects: 167
Study: 24886906

Group type: EXPERIMENTAL
Intervention: Early surfactant treatment (Curosurf®)
Number of subjects: 2

Group type: COMPARATOR
Intervention: Late surfactant treatment (Curosurf®)
Number of subjects: 2
Study: 23078486

Group type: EXPERIMENTAL
Intervention: Walking-plus-social marketing program
Number of subjects: 424

Group type: COMPARATOR
Intervention: Walking-only program
Number of subjects: 424

Group type: EXPERIMENTAL
Intervention: Peer-led Pride Strides (social marketing component)
Number of subjects: 424

Group type: EXPERIMENTAL
Intervention: Social marketing approach
Number of subjects: 424
Study: 20370916

Group type: EXPERIMENTAL
Intervention: Tranexamic acid (TXA)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Epsilon aminocaproic acid (EACA)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 18656509

Group type: EXPERIMENTAL
Intervention: Khat leaves
Number of subjects: 6

Group type: COMPARATOR
Intervention: Lettuce
Number of subjects: 6
Study: 15752382

Group type: EXPERIMENTAL
Intervention: Exemestane 25 mg as a sugar-coated tablet (SCT) after fasting
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Exemestane 25 mg as a sugar-coated tablet (SCT) after food
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Exemestane 25 mg as a suspension after fasting
Number of subjects: 12
Study: 11772328

Group type: EXPERIMENTAL
Intervention: Enteral nutrition (elemental, semi‐elemental or polymeric diet) as the sole source of nutrition
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional corticosteroids
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ileal‐release preparation of budesonide
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 6‐Mercaptopurine (6‐MP) and its prodrug azathioprine
Number of subjects: 0
Study: 10479170

Group type: EXPERIMENTAL
Intervention: PVL nadir below the limit of detection (LOD)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PVL nadir detectable but not quantifiable
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PVL nadir below the LOD
Number of subjects: 0

Group type: COMPARATOR
Intervention: PVL nadir >500 copies/mL
Number of subjects: 0
Study: 8951265

Group type: EXPERIMENTAL
Intervention: Zinc supplementation (10 mg of elemental zinc daily)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Control group (no zinc supplementation)
Number of subjects: 93
Study: 1618246

Group type: EXPERIMENTAL
Intervention: 4.4 ml of 2% lignocaine with 1:80,000 adrenaline
Number of subjects: 16

Group type: COMPARATOR
Intervention: 3% prilocaine with 0.03 IU.ml‐1 felypressin
Number of subjects: 16
Study: 6367098

Group type: EXPERIMENTAL
Intervention: Atenolol 100 mg plus chlorthalidone 25 mg (Tenoretic)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sotalol 320 mg plus hydrochlorothiazide 50 mg (Sotazide)
Number of subjects: 0
Study: 30695290

Group type: EXPERIMENTAL
Intervention: Cariprazine (3, 6, or 9 mg/d)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study: 28779419

Group type: EXPERIMENTAL
Intervention: Budesonide 2 mg/25 ml foam
Number of subjects: 126

Group type: COMPARATOR
Intervention: Placebo foam
Number of subjects: 126
Study: 26872828

Group type: EXPERIMENTAL
Intervention: Whole Body Vibration (WBV)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Local Muscle Vibration (LMV)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control
Number of subjects: 60
Study: 24731008

Group type: EXPERIMENTAL
Intervention: Low-dose fructose infusion
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (normal glucose tolerance)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hyperglycemia
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Euglycemia
Number of subjects: 0
Study: 22414844

Group type: COMPARATOR
Intervention: NaOCl irrigation without LAI (group N)
Number of subjects: 63

Group type: COMPARATOR
Intervention: EDTA irrigation without LAI (group E)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: LAI with NaOCl (group NL)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: LAI with EDTA (group EL)
Number of subjects: 63
Study: 19889010

Group type: EXPERIMENTAL
Intervention: Fractional laser treatment (1,540-nm erbium glass laser)
Number of subjects: 12
Study: 18418976

Group type: EXPERIMENTAL
Intervention: Yishen Tiaojing Recipe (YSTJR) plus TP 20 mg three times a day
Number of subjects: 58

Group type: COMPARATOR
Intervention: TP 20 mg three times a day (Control)
Number of subjects: 58
Study: 15997346

Group type: EXPERIMENTAL
Intervention: Linear catheter ablation
Number of subjects: 25
Study: 12520149

Group type: EXPERIMENTAL
Intervention: Intraaortic balloon pumping (IABP)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Control group (no IABP)
Number of subjects: 51
Study: 10380745

Group type: EXPERIMENTAL
Intervention: Bupivacaine (2.5 mg/ml) + epinephrine (5 microg/ml)
Number of subjects: 126

Group type: COMPARATOR
Intervention: Epinephrine (5 microg/ml) + saline (9 mg/ml)
Number of subjects: 126

Group type: COMPARATOR
Intervention: Saline (9 mg/ml) only
Number of subjects: 126
Study: 8885909

Group type: EXPERIMENTAL
Intervention: Dilute vasopressin solution (0.05 U/mL)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Placebo (normal saline)
Number of subjects: 106
Study: 1998274

Group type: EXPERIMENTAL
Intervention: Lovastatin 20 or 40 mg once or twice daily
Number of subjects: 8245

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8245
Study: 6880927

Group type: EXPERIMENTAL
Intervention: Edible incentive
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Non-edible incentive
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Preference for food vs non-food items
Number of subjects: 40
Study: 31964335

Group type: EXPERIMENTAL
Intervention: Daily iron supplementation of ferrous sulfate between 80 mg and 160 mg.
Number of subjects: 43

Group type: COMPARATOR
Intervention: Not applicable (observational study with no control group).
Number of subjects: 43
Study: 31438346

Group type: COMPARATOR
Intervention: No feedback (Control)
Number of subjects: 0
Study: 30337921

Group type: EXPERIMENTAL
Intervention: HFA-134a-beclomethasone dipropionate (HFA-BDP) metered-dose inhaler (MDI) ETN (n = 11)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: HFA-134a-beclomethasone dipropionate (HFA-BDP) metered-dose inhaler (MDI) ETN
Number of subjects: 23
Study: 27494176

Group type: EXPERIMENTAL
Intervention: GTE confection (1 g of green tea extract)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Starch confection without GTE
Number of subjects: 15

Group type: COMPARATOR
Intervention: Both confections (GTE and control)
Number of subjects: 15
Study: 24864465

Group type: EXPERIMENTAL
Intervention: Intravenous meldonium (idrinol) 1000 mg/day for 10-14 days
Number of subjects: 60

Group type: COMPARATOR
Intervention: Basic therapy of coronary heart disease (Control Group)
Number of subjects: 60
Study: 22439290

Group type: EXPERIMENTAL
Intervention: Problem-solving Treatment-OcOccupational Therapy (PST-OT)
Number of subjects: 80
Study: 19006186

Group type: EXPERIMENTAL
Intervention: Bilateral fetal nigral transplantation with 4 donors per side
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Bilateral fetal nigral transplantation with 1 donor per side
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: All groups (on‐medication dyskinesia)
Number of subjects: 34
Study: 17766719

Group type: EXPERIMENTAL
Intervention: 0.33 mmol/kg calcium gluconate intravenously for 3 hours
Number of subjects: 16

Group type: COMPARATOR
Intervention: Calcium loading test in PHP patients
Number of subjects: 16
Study: 16047182

Group type: EXPERIMENTAL
Intervention: Rofecoxib 50 mg
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80